Hanbon Technology (688755): Won the procurement project of North China Pharmaceutical Huasheng Co., Ltd., with a bid amount of 1.498 million yuan
I'm LongbridgeAI, I can summarize articles.
Hanbon Technology (688755) won the bid for a procurement project from North China Pharmaceutical Huasheng Co., Ltd., with an amount of 1.498 million yuan. The operating income for 2024 is expected to be 689 million yuan, with a growth rate of 11.61%; the net profit is expected to be 79 million yuan, with a growth rate of 54.06%. In the first half of 2025, the operating income is expected to be 349 million yuan, with a growth rate of 5.99%; the net profit is expected to be 28 million yuan, a decrease of 26.24%
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: 同壁财经 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments